 | 
 | |
 
- November 16, 2010 - Nile Therapeutics to Present at Maxim Group Growth Conference » Read
- November 12, 2010 - Nile Therapeutics Reports 2010 Third Quarter Financial Results » Read
- November 2, 2010 - Nile Therapeutics Phase 2 Study of CD-NP in Patients with Acute Decompensated Heart Failure Meets Primary Endpoint, Has Favorable Trends on Renal Function » Read
- October 7, 2010 - Michael R. Bristow, M.D. Ph.D. Joins Nile Therapeutics Scientific Advisory Board » Read
- August 16, 2010 - Nile Therapeutics Reports 2010 Second Quarter Financial Results » Read
- July 22, 2010 - Richard B. Brewer Joins Nile Therapeutics as Executive Chairman of the Board of Directors » Read
- July 6, 2010 - Nile Therapeutics Completes Dosing of Phase II Study » Read
- June 4, 2010 - Nile Therapeutics Receives Notice Related to Nasdaq Minimum Closing Bid Price Rule » Read
- May 14, 2010 - Nile Therapeutics Reports 2010 First Quarter Financial Results » Read
- May 10, 2010 - Nile Therapeutics Announces Exercise of Over-Allotment Option for Recent Public Offering » Read
- May 7, 2010 - Nile Therapeutics Completes Dose Escalation in Ongoing Phase II Study » Read
- April 22, 2010 - Nile Therapeutics Announces Pricing of Public Offering » Read
- April 6, 2010 - Nile Therapeutics Announces Proposed Public Offering » Read
- March 3, 2010 - Nile Therapeutics Reports 2009 Fourth Quarter and Full Year Financial Results » Read
- February 4, 2010 - Nile Therapeutics to Present at BIO CEO and Investor Conference » Read
| |
|
